In reply

Ann Emerg Med. 2013 Oct;62(4):433. doi: 10.1016/j.annemergmed.2013.04.015.

Authors

Jonathan A Edlow¹, Eric E Smith

Affiliation

¹ Harvard Medical School, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

PMID: 24054100
DOI: 10.1016/j.annemergmed.2013.04.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Emergency Service, Hospital / standards*
Fibrinolytic Agents / therapeutic use*
Humans
Stroke / drug therapy*
Tissue Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator